Literature DB >> 26155427

Delineating CSF-1-dependent regulation of myeloid cell diversity in tumors.

Amy-Jo Casbon1, Marja Lohela1, Zena Werb1.   

Abstract

Myeloid cells contribute to increased malignancy and poor prognosis in breast cancer. We demonstrate that anti-CSF-1R therapy depletes a cell population sharing characteristics of tumor-associated macrophages (TAMs) and dendritic cells (DCs). Intravital imaging combined with cellular characterization has refined our understanding of anti-CSF-1R therapy on the tumor microenvironment.

Entities:  

Keywords:  M-CSF; MMP, matrix metalloproteinase; TAM, tumor-associated macrophages; breast cancer; matrix metalloproteinase; tumor microenvironment; tumor-associated macrophages

Year:  2015        PMID： 26155427      PMCID： PMC4485713          DOI： 10.1080/2162402X.2015.1008871

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

Review 2.  Tumors as organs: complex tissues that interface with the entire organism.

Authors:  Mikala Egeblad; Elizabeth S Nakasone; Zena Werb
Journal:  Dev Cell       Date:  2010-06-15       Impact factor: 12.270

3.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils.

Authors:  Amy-Jo Casbon; Damien Reynaud; Chanhyuk Park; Emily Khuc; Dennis D Gan; Koen Schepers; Emmanuelle Passegué; Zena Werb
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations.

Authors:  Marja Lohela; Amy-Jo Casbon; Aleksandra Olow; Lynn Bonham; Daniel Branstetter; Ning Weng; Jeffrey Smith; Zena Werb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

Review 5.  Balancing the innate immune system in tumor development.

Authors:  Catharina Hagerling; Amy-Jo Casbon; Zena Werb
Journal:  Trends Cell Biol       Date:  2014-11-28       Impact factor: 20.808

6.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

7.  The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.

Authors:  Agnieszka Swierczak; Andrew D Cook; Jason C Lenzo; Christina M Restall; Judy P Doherty; Robin L Anderson; John A Hamilton
Journal:  Cancer Immunol Res       Date:  2014-04-29       Impact factor: 11.151

Review 8.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.

Authors:  David A Hume; Kelli P A MacDonald
Journal:  Blood       Date:  2011-12-20       Impact factor: 22.113

Review 9.  Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression.

Authors:  Damya Laoui; Eva Van Overmeire; Patrick De Baetselier; Jo A Van Ginderachter; Geert Raes
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

10.  Macrophage activation and polarization: nomenclature and experimental guidelines.

Authors:  Peter J Murray; Judith E Allen; Subhra K Biswas; Edward A Fisher; Derek W Gilroy; Sergij Goerdt; Siamon Gordon; John A Hamilton; Lionel B Ivashkiv; Toby Lawrence; Massimo Locati; Alberto Mantovani; Fernando O Martinez; Jean-Louis Mege; David M Mosser; Gioacchino Natoli; Jeroen P Saeij; Joachim L Schultze; Kari Ann Shirey; Antonio Sica; Jill Suttles; Irina Udalova; Jo A van Ginderachter; Stefanie N Vogel; Thomas A Wynn
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745
  10 in total
  5 in total

Review 1.  Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Authors:  Mariona Cabo; Rienk Offringa; Laurence Zitvogel; Guido Kroemer; Aura Muntasell; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

2.  CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling.

Authors:  Yan Xia Yu; Hai Jian Wu; Bing Xu Tan; Chen Qiu; Hui Zhong Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

3.  Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1.

Authors:  Huayang Wang; Qianqian Shao; Jintang Sun; Chao Ma; Wenjuan Gao; Qingjie Wang; Lei Zhao; Xun Qu
Journal:  Oncoimmunology       Date:  2016-01-04       Impact factor: 8.110

Review 4.  Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters.

Authors:  Gabor J Szebeni; Csaba Vizler; Klara Kitajka; Laszlo G Puskas
Journal:  Mediators Inflamm       Date:  2017-01-18       Impact factor: 4.711

Review 5.  Roles of the immune system in cancer: from tumor initiation to metastatic progression.

Authors:  Hugo Gonzalez; Catharina Hagerling; Zena Werb
Journal:  Genes Dev       Date:  2018-10-01       Impact factor: 11.361
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.